DEA schedule
Is maraviroc a controlled substance?
Federal schedule for maraviroc from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Maraviroc is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and maraviroc is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted maraviroc?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 19 prescription listings from 9 labelers, none with a DEA schedule |
| DEA controlled substances list | maraviroc is not on the list |
Maraviroc NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 49702-223 | SELZENTRY | tablet, film coated | 150 mg/1 | ViiV Healthcare Company | None |
| 50090-6238 | SELZENTRY | tablet, film coated | 150 mg/1 | A-S Medication Solutions | None |
| 49702-224 | SELZENTRY | tablet, film coated | 300 mg/1 | ViiV Healthcare Company | None |
| 31722-579 | Maraviroc | tablet, film coated | 150 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 42858-246 | Maraviroc | tablet, film coated | 150 mg/1 | Rhodes Pharmaceuticals LLC | None |
| 50090-8010 | Maraviroc | tablet, film coated | 150 mg/1 | A-S Medication Solutions | None |
| 68475-008 | Maraviroc | tablet, film coated | 150 mg/1 | Navinta LLC | None |
| 70710-1930 | Maraviroc | tablet, film coated | 150 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 72319-024 | Maraviroc | tablet, film coated | 150 mg/1 | i3 Pharmaceuticals, LLC | None |
| 72865-231 | Maraviroc | tablet, film coated | 150 mg/1 | XLCare Pharmaceuticals Inc. | None |
| 73141-024 | Maraviroc | tablet, film coated | 150 mg/1 | A2A Integrated Pharmaceuticals | None |
| 31722-580 | Maraviroc | tablet, film coated | 300 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 42858-247 | Maraviroc | tablet, film coated | 300 mg/1 | Rhodes Pharmaceuticals LLC | None |
| 50090-8005 | Maraviroc | tablet, film coated | 300 mg/1 | A-S Medication Solutions | None |
| 68475-007 | Maraviroc | tablet, film coated | 300 mg/1 | Navinta LLC | None |
| 70710-1931 | Maraviroc | tablet, film coated | 300 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 72319-025 | Maraviroc | tablet, film coated | 300 mg/1 | i3 Pharmaceuticals, LLC | None |
| 72865-232 | Maraviroc | tablet, film coated | 300 mg/1 | XLCare Pharmaceuticals Inc. | None |
| 73141-025 | Maraviroc | tablet, film coated | 300 mg/1 | A2A Integrated Pharmaceuticals | None |
Questions
Is maraviroc a controlled substance?
No. Maraviroc is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and maraviroc is not on the DEA controlled substances list.
Is maraviroc a narcotic?
No. Maraviroc is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is CCR5 Co-receptor Antagonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.